Michael Helmrath · Evaluation of transplantation sites for human intestinal organoids
Follow
Article1 min read·Published Aug 2020Older

Evaluation of transplantation sites for human intestinal organoids

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Aug 2020 · 1 min read

In brief

In brief

This study compares two transplantation sites for human intestinal organoids derived from embryonic stem cells: renal subcapsular space versus mesentery. While mesenteric transplantation showed higher mortality but better engraftment rates with fewer lumens, both sites produced similar tissue quality and differentiation markers after 10 weeks.

Written by the GCMD Library team from the article.

Michael Helmrath

Our group has developed two transplantation models for the engraftment of Human Intestinal Organoids (HIOs): the renal subcapsular space (RSS) and the mesentery each with specific benefits for study. While engraftment at both sites generates laminated intestinal structures, a direct comparison between models has not yet been performed. Embryonic stem cells were differentiated into HIOs, as previously described. HIOs from the same batch were transplanted on the same day into either the RSS or mesentery. 10 weeks were allowed for engraftment and differentiation, at which time they were harvested and assessed. Metrics for comparison included: mortality, engraftment rate, gross size, number and grade of lumens, and expression of markers specific to epithelial differentiation, mesenchymal differentiation, and carbohydrate metabolism. Mortality was significantly increased when undergoing mesentery transplantation, however engraftment was significantly higher. Graft sizes were similar between groups. Morphometric parameters were similar between groups, however m-tHIOs presented with significantly fewer lumens than k-tHIO. Transcript and protein level expression of markers specific to epithelial differentiation, mesenchymal differentiation, and carbohydrate metabolism were similar between groups. Transplantation into both sites yields viable tissue of similar quality based on our assessments with enhanced engraftment and a dominant lumen for uniform study benefiting the mesenteric si

Statements in this article

  1. Human intestinal organoids can be transplanted into either the renal subcapsular space or the mesentery for engraftment studies.

    Established
  2. Ten weeks are allowed for engraftment and differentiation of transplanted human intestinal organoids before harvest and assessment.

    Recommendation
  3. Mortality is significantly increased when transplanting human intestinal organoids into the mesentery compared to the renal subcapsular space.

    Research
  4. Engraftment rate is significantly higher for mesenteric transplantation compared to renal subcapsular transplantation.

    Research
  5. Graft sizes are similar between renal subcapsular and mesenteric transplantation sites.

    Research
  6. Mesenteric transplanted human intestinal organoids present with significantly fewer lumens than renal subcapsular transplanted organoids.

    Research
  7. Expression of markers specific to epithelial differentiation, mesenchymal differentiation, and carbohydrate metabolism are similar between renal subcapsular and mesenteric transplantation sites.

    Research
  8. Both transplantation sites yield viable tissue of similar quality based on morphometric and molecular assessments.

    Research

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →